Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,438 | -5,774 | -3,770 | -3,399 | -1,816 |
| Depreciation Amortization | 69 | 278 | 210 | 141 | 174 |
| Accounts receivable | 86 | -872 | -729 | -463 | 14 |
| Accounts payable and accrued liabilities | 1,852 | -203 | 304 | 18 | -122 |
| Other Working Capital | 2,002 | -902 | -197 | -301 | 88 |
| Other Operating Activity | -3,451 | 2,420 | 1,014 | 1,616 | 44 |
| Operating Cash Flow | $-879 | $-5,053 | $-3,168 | $-2,389 | $-1,618 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | N/A | N/A | N/A | -213 |
| Common Stock Issued | 43 | 12,165 | 12,071 | 3,981 | 3,206 |
| Financing Cash Flow | $43 | $12,165 | $12,071 | $3,981 | $2,993 |
| Beginning Cash Position | 6,847 | 2,020 | 2,020 | 2,020 | 2,020 |
| End Cash Position | 5,467 | 6,847 | 8,983 | 2,593 | 3,810 |
| Net Cash Flow | $-1,380 | $4,827 | $6,963 | $573 | $1,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -879 | -5,053 | -3,168 | -2,389 | -1,618 |
| Free Cash Flow | -879 | -5,053 | -3,168 | -2,389 | -1,618 |